C., Sato, A
J Exp Clin Cancer Res 40(1):114 Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M et al (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways
Pyroptosis is a highly inflammatory form of cell death that can be abnormally activated by oxidative stress, endoplasmic reticulum stress, and pro-inflammatory cytokines, thereby impairing ovarian function
Galperin, M
Used when the research compound is sold as a lyophilized vial
References Lancet Diabetes Endocrinology (2024) Efficacy and safety of coadministered onceweekly cagrilintide 2.4 mg with Semaglutide 2.4 mg in type 2 diabetes: phase 2 trial Lancet (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant cagrilintide with Semaglutide 2.4 mg: phase 1b trial Lancet (2021) Onceweekly cagrilintide for weight management: dosefinding phase 2 trial in overweight/obesity StatPearls (2025) Semaglutide: pharmacology, indications, and clinical use overview Cureus (2024) Semaglutide: risks and benefits review (PMC) WHO (2010) Best practices for injection and related procedures (WHO toolkit) SigmaAldrich (2016) Peptide Handling Guide: storage, reconstitution, and stability LibreTexts (2020) Intradermal and subcutaneous injections: clinical procedures CDC (2024) Vaccine administration: subcutaneous injection technique Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
